Literature DB >> 31909314

Efficient Rapid Access to Biginelli for the Multicomponent Synthesis of 1,2,3,4-Tetrahydropyrimidines in Room-Temperature Diisopropyl Ethyl Ammonium Acetate.

Chetan K Jadhav1, Amol S Nipate1, Asha V Chate1, Vishal D Songire1, Anil P Patil2, Charansingh H Gill1.   

Abstract

The diisopropyl ethyl ammonium acetate (DIPEAc)-promoted Biginelli protocol has been developed for the first time by a successive one-pot three-component reaction of aldehydes, ethylcyanoacetate/ethyl acetoacetate, and thiourea/urea to afford pharmacologically promising 1,2,3,4-tetrahydropyrimidines in high yields at room temperature. The key benefits of the present scheme are the capability to allow a variability of functional groups, short reaction times, easy workup, high yields, recyclability of the catalyst, and solvent-free conditions, thus providing economic and environmental advantages. In addition, a series of 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles analogues were synthesized and selected for their in vitro antifungal and antibacterial activities.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31909314      PMCID: PMC6941212          DOI: 10.1021/acsomega.9b02286

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Room-temperature ionic liquids (RTILs) have taken the attention of the chemical community all over the globe as a green alternative option to traditional ecofriendly media for catalysis, synthesis, separation, and other several chemical tasks.[1−7] RTILs include numerous exclusive properties, such as extensive liquid range, nonvolatility, low toxicity, high thermal stability, noncombustible, excellent solubility, and recyclability.[8] RTILs act as “neoteric solvents” for a wide range of industrial and chemical processes. In recent times, RTILs have been originating to be valuable as environmental friendly media for multitudinous organic revolutions.[9,10] On the other hand, multicomponent reactions (MCRs) are one of the more dominant and practical tackles in organic synthesis for the creation of pharmacologically relevant frameworks from the point of view of green chemistry. MCRs give benefits of atom economy, high yields, flexibility, target specificity, and especially one-pot operation;[11−13] the discrimination and returns of the MCRs are significantly affected by the choice of an appropriate catalyst. Thus, the introduction of a dynamic, inexpensive, mild, and environmental friendly catalyst for significant MCRs superior to analogues of pharmaceutical and biological prominence is in demand. In this paper, we have validated DIPEAc as ionic liquid catalyzed the efficient synthesis of 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile analogues via one-pot multicomponent reactions under ecofriendly reaction conditions (Schemes and 2).
Scheme 1

Synthesis of 4-Oxo-6-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4a) by Using DIPEAc as RTIL

Scheme 2

Synthesis of Diisopropylethylammonium Acetate (DIPEAc)

The pyrimidine moiety is an essential part of RNA and DNA, providing various biological properties such as potent fungicide and bactericide.[14] Some pyrimidine analogues are also known to acquire anticancer,[15] antimalarial,[16] antiviral,[17] antibacterial,[18,19] antifungal,[20,21] anticonvulsant,[22] and antihistamine[23] activities. Certain 3,4-dihydropyrimidines have developed as essential props of numerous calcium antihypertensive agents, adrenergic, channel blockers, and neuropeptide antagonists.[24] A number of natural marine products accommodate the 3,4-dihydropyrimidine nucleus, described in the literature for remarkable anti-HIV alkaloid batzelladine B activities (Figure ).[25,26]
Figure 1

Pyrimidine-incorporated bioactive molecules.

Thus, the enlargement of synthetic strategies for the creation of this molecule using an inexpensive, reusable, mild, and nontoxic catalyst is of enormous significance from the industrial and academic points of view. Even though various modes have been reported in the literature, the Biginelli MCR is moderately versatile because it can be implemented with numerous chemical takes in all three key components (i.e., aldehyde, β-ketoester, and thiourea or urea) paramount to a manifold of thiones/dihydropyrimidinones.[27] These reactions can be accomplished under a variability of tentative conditions, and several improvements have been reported in recent years, such as p-TsOH·H2O,[28] H3BO3,[29] [Al(H2O)6](BF4)3,[30] thiamine hydrochloride,[31] imidazole-1-yl-acetic acid,[32] l-(+)-tartaric acid-dimethylurea,[32] HClO4–SiO2,[33,34] SnCl2·2H2O,[35] polymer-supported benzimidazolium-based ionic liquid,[36] basic IL,[37] Al-plante MCM-41,[38] (NH4)2CO3,[39] CeCl3·7H2O,[40] CaCl2,[39] Ce(NH4)2(NO3)6polyvinylsulfonic acid,[34] and Fe(OTs)3·6H2O.[41] However, numerous of these testified methods become infected with several disadvantages such as strong acidic conditions, use of hazardous or costly reagents, long reaction times, low yields of products, and sophisticated treatment. Moreover, many of these schemes utilize organic solvents as the reaction medium. Hence, innovative, competent, and ecofriendly procedures are still powerfully needed to generate pharmacologically active molecules. As per our investigation, the existential of this work is to begin a rapid and efficient Biginelli multicomponent synthetic protocol for obtaining 1,2,3,4-tetrahydropyrimidines under ecofriendly conditions. As an extension of emerging economic and efficient MCR strategy to develop pharmaceutically and biologically significant molecules,[42] herein, we reported a first-time three-component method in DIPEAc at room temperature to access a library of 1,2,3,4-tetrahydropyrimidine in good to excellent yields.

Results and Discussion

Chemistry

To achieve optimized conditions for the Biginelli protocol based on the reaction of benzaldehyde (1a) (3 mmol), ethylcyanoacetate (2) (3 mmol), and thiourea (3) (3.2 mmol) as model substrates, we checked altered catalysts, temperatures, and solvents, and the results of this study are summarized in Table . It was found that when the reaction was carried out in the nonappearance of the catalyst in ethanol, no product was perceived, even after 9 h (Table , entry 1). To obtain the preferred product (4a), we tested the reaction using different catalysts such as Cs2CO3, p-TSA, β-CD, CTAB, SDS, ChCl:2urea, ChCl:2ZnCl2, PEG-400, DIPEAc, and dicationic ionic liquid (Table , entries 2–11). Thus, room-temperature DIPEAc as the pre-eminent catalyst was tested for this reaction. In the presence of DIPEAc, compound 4a was isolated in 93% yield after only 45 min at room temperature. The model reaction in water using phase transfer catalysts is found to be sluggish and formed the desired 4a in less yields. Therefore, it can be thought that DIPEAc is green and a superior solvent and catalyst compared to the others shown in Table .
Table 1

Efficiency Comparison of Various Catalysts for the Synthesis of 4-Oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4a)a

entrycatalystmediumtimeyieldb (%)/time (h)
1 EtOH9 htrace
2Cs2CO3EtOH7 h61
3p-TSAH2O7 h68
4β-CDH2O6 h65
5CTABH2O6 h59
6SDSH2O6 h52
7ChCl:2ureaChCl:2urea2 h80
8ChCl:2ZnCl2ChCl:2ZnCl23 h76
9PEG-400PEG-4006 h74
10DIPEAcDIPEAc45 min94
11dicationic ionic liquiddicationic ionic liquid7 h73

Reaction conditions: aldehyde (3 mmol), ethylcyanoacetate (3 mmol), thiourea (3.2 mmol) in medium (5 mL), stirred at room temperature.

Isolated yields b: no condensation. Bold values are for highlighting the good result.

Reaction conditions: aldehyde (3 mmol), ethylcyanoacetate (3 mmol), thiourea (3.2 mmol) in medium (5 mL), stirred at room temperature. Isolated yields b: no condensation. Bold values are for highlighting the good result. The amount of the catalyst is another critical parameter in terms of reaction efficiency. To confirm the amount of the DIPEAc, the model reaction was examined by a set of experiments by the varying amounts from 1 to 5 mL; as the amount of DIPEAc increases gradually, a steady increase was observed in the product yield. DIPEAc (4 mL) furnishes 4a in 96% yield at room temperature (Table , entries 1). Further increase in the amount of DIPEAc does not increase in the yield of the product. The model reaction was carried out without any catalyst and solvent; the trace amount of the product was achieved after a long period (Table , entry 1). Further, the efficiency of DIPEAc was checked by using 20 mol % DIPEAc in various solvents (Table , entries 7–12). In ethanol, the reaction takes place smoothly with high yield. While in water, MeOH, acetonitrile, DCM, CH2Cl2, and DMF reaction proceeds with lower yields at reflux temperature. None of the solvents exist the advantage of time and yield over the solvent-free condition. Hence, the solvent-free condition was regarded as the finest for the cost and environmental suitability.
Table 2

Solvent Effects on the Reaction of Aldehyde, Ethylcyanoacetate, and Thiourea for the Synthesis of 4-Oxo-6-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4a)a

entryDIPEActemp. (°C)solventtime (min)yield (%)b
10RT 24htrace
21 mLRT 4560
32 mLRT 4575
43 mLRT 4580
54 mLRT 4596
65 mLRT 4595
720 mol %refluxH2O32075
820 mol %refluxEtOH32080
920 mol %refluxMeOH32075
1020 mol %refluxCH3CN32055
1120 mol %refluxCH2Cl232052
1220 mol %refluxDMF32050

Reaction conditions: aldehyde (3 mmol), ethylcyanoacetate (3 mmol),thiourea (3.2 mmol) in solvent (5 mL), stirred at room temp.

Isolated yields. Bold values are for highlighting the good result.

Reaction conditions: aldehyde (3 mmol), ethylcyanoacetate (3 mmol),thiourea (3.2 mmol) in solvent (5 mL), stirred at room temp. Isolated yields. Bold values are for highlighting the good result. In summary, the highest efficiency and fastest reaction time for the model Biginelli reaction was observed at room temperature by using 4 mL of DIPEAc. Having ideal conditions in hand, the adaptability of the protocol was examined for the construction of 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles (4a–v). Various substituents on aldehyde including methyl, methoxy, cyano, nitro, halogen (−Cl, −F, −Br), and hydroxyl moieties were used. The results of all reactions performed under these conditions are shown in Table . Aldehyde containing electron-donating groups such as −Me, −OMe, and electron-withdrawing group such as −NO2 on the aromatic ring was compatible with this transformation, and corresponding 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles (4a–v) were obtained in good to high yields. To our enchantment, halogen-substituted 2-benzylidene malononitrile gave the products with high yields (4g, 4h, and 4l). Moreover, sterically crowded di- and trisubstituted benzaldehyde provided the desired products in high yields (4i, 4j, and 4r). The heteroaryl aldehydes and aliphatic aldehydes also keep well under the present reaction conditions without any difficulties (4m, 4t, and 4w–4zz).
Table 3

Recycling of DIPEAc (IL) for The Synthesis of Compounds 4a and 4aaa

runcatalyst recoveryproduct yield (%)
19696
29293
39190
49089
58078

Reaction conditions: aldehyde (3 mmol), ethylcyanoacetate (3 mmol),thiourea/urea(3.2 mmol) in solvent (4 mL), stirred at room temp. Bold values are for highlighting the good result.

Reaction conditions: aldehyde (3 mmol), ethylcyanoacetate (3 mmol),thiourea/urea(3.2 mmol) in solvent (4 mL), stirred at room temp. Bold values are for highlighting the good result. For assessing the generality of optimized reaction conditions, we considered the scope of the reaction by the cyclocondensation of aldehydes, ethyl acetoacetate, and urea/thiourea in DIPEAc at room temperature. DIPEAc also acts as an efficient promoter to catalyze the synthesis of ethyl 6-methyl-4-(4-substitutedphenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate in high yields (Table , entries 21–30). The Biginelli formation of 1,2,3,4-tetrahydropyrimidine derivatives has been confirmed by spectroscopic techniques and physical data such as IR, 1H NMR, 13C NMR, and liquid chromatography–mass spectrometry (LCMS). According to the 1H NMR spectrum of representative compound 4a, the characteristic two singlet’s at 11.71 and 8.96 for two protons of −NH group present in pyrimidine ring, 7.52–7.56 ppm and a doublet at 7.78–7.81 four protons present in phenyl ring confirmed the 4a. 13C NMR spectral data, in which the carbon signals of −SCH2 and −NCH2 groups, were resonated at 183.29 and 183.53 ppm, respectively. The signals at 166.22 point out the presence of the carbonyl carbon atom, while all further carbons gave peaks at expected values. Again, the construction of compound 4a was confirmed by LCMS: m/z [M + Na]+. The calculated m/z for compound 4a C11H7N3OSNa+ is 252.2 and observed at 252.2 [M + Na]+. Pyrimidine-incorporated bioactive molecules.

Recycling of the Catalyst

Effectual reusability and recovery of the ionic liquid are other significant features of our proposed protocol. We check the reusability of the catalyst. The reaction was performed between aldehyde, ethylcyanoacetate, and thiourea under the optimized reaction conditions. DIPEAc was disconnected from the reaction mixture by the following procedure. After completion of the reaction, the reaction mixture was cooled to room temperature, and then, water and ethyl acetate were added. The product (4a) was extracted with ethyl acetate. As the DIPEAc is highly water-soluble, it goes into the aqueous layer. Evaporation of the aqueous layer under reduced pressure provided the catalyst (DIPEAc). Recyclability graph of catalytic efficiency of DIPEAc was tested for four consecutive cycles; the isolated yields were almost alike until the fourth recycling (Figure ), but a reduction in the catalytic activity of DIPEAc was observed after the fifth cycle; the outcomes are summarized in Table . Furthermore, in order to explore the stability of DIPEAc during four consecutive runs, the IR spectra of the recovered DIPEAc (after four cycles) were matched with those of the fresh sample. As documented in Figure , the IR spectra displayed by the recovered catalyst were found to be almost similar to the fresh one.
Figure 2

Reuse and recovery of DIPEAc and its effect on yield.

Figure 3

IR spectrum of reuse and recovery of DIPEAc (pink spectrum: fresh; green spectrum: after IV recycles).

Reuse and recovery of DIPEAc and its effect on yield. IR spectrum of reuse and recovery of DIPEAc (pink spectrum: fresh; green spectrum: after IV recycles). Structure–activity relationship of hybrid compounds.

Plausible Reaction Mechanism

To explain the mechanism of this one-pot three-component cyclocondensation leading to 1,2,3,4-tetrahydropyrimidine is accredited to the exclusive role of DIPEAc as a medium. It has the capacity to dissolve a number of inorganic/organic solutes readily. This might sensibly maintain the high concentrations of the reactants while initiating the reaction and even the progress of the reaction. Hence high to saturate the solutions of the reactants in the reaction mass would be responsible for degree acceleration of Biginelli reaction. The stronger hydrogen bonding capability of DIPEAc and the motives for this could be elucidated as follows: (1) The use of DIPEAc elevated the solubility of reactants, which leads to superior interfacial area and lower mass transfer resistance.[43] (2) The stimulating effects of DIPEAc to the reaction could be endorsed to its polarity, hydrobonding, and hydrophobic effects.[44] Hydrophobic effect: The hydrophobic effect leads to extraordinary negative volume of initiation which means better stabilization of activated complexes than hydrophobic reactants in the reaction. Polarity effect: The high polarity of DIPEAc outcomes in the extra polar interpreted states than primary states, so the reaction promptness can be improved. Hydrogen-bonding effect: DIPEAc could initiate the reactants and intermediate products by forming the hydrogen bonds with the hydroxyl oxygen and carbonyl oxygen, respectively (Schemes and 4), constructing them easy to form consistent products. It was assumed that only polar protic solvents could give the preferred product, and the hydrogen-bonding effect is the core difference between polar protic solvents and other solvents, so the hydrogen-bonding effect may be the important factor to promote the reaction. Then, it might improve the electrophilic character of carbonyl carbon of the reactants, namely, aldehyde and intermediate. It also increases the rate of in situ formation of catenation from ethylcyanoacetate/ethyl acetoacetate. They may be causing the rate of acceleration resulting in high yields of the 1,2,3,4-tetrahydropyrimidine, subsidiary the role of DIPEAc in a rate enhancement. The proposed mechanism has gone through the Knoevenagel condensation followed by Michael addition and then intermolecular cyclization that is presented in Scheme .
Scheme 3

Synthesis of 4-Oxo-6-aryl-2-thioxo-1,2,3,4-Tetrahydropyrimidine-5-carbonitriles (4a–z) by Using DIPEAc as RTIL

Reaction conditions: Aldehydes (1a–z) (3 mmol), ethylcyanoacetate/ethyl acetoacetate (3 mmol), and thiourea/urea (3.2 mmol) in DIPEAc (4 mL) stirred at room temp;

isolated yields,

melting points are in good contact with those reported in the literature.[36,50,51]

Scheme 4

Synthesis of Ethyl 6-Methyl-2-oxo-4-aryl-1,2,3,4-tetrahydropyrimidine-5-carboxylates (4aa–nn) by Using DIPEAc as RTIL

Reaction conditions: aldehyde (1aa–nn) (3 mmol), ethylcyanoacetate/ethyl acetoacetate (3 mmol), thiourea/urea (3.2 mmol) in DIPEAc (4 mL), stirred at room temp;

isolated yields,

melting points are in good contact with those reported in the literature.[36,50,51]

Scheme 5

4-Oxo-6-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile

Synthesis of 4-Oxo-6-aryl-2-thioxo-1,2,3,4-Tetrahydropyrimidine-5-carbonitriles (4a–z) by Using DIPEAc as RTIL

Reaction conditions: Aldehydes (1a–z) (3 mmol), ethylcyanoacetate/ethyl acetoacetate (3 mmol), and thiourea/urea (3.2 mmol) in DIPEAc (4 mL) stirred at room temp; isolated yields, melting points are in good contact with those reported in the literature.[36,50,51]

Antimicrobial Screening

Twenty analogues of 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles (4a–t) were evaluated against four bacterial Streptococcus pyogenes, Escherichia coli,S. aureus, and Pseudomonas aeruginosa, and two fungal C. Albicans and Aspergillus niger strains. Ampicillin, rifampicin, and rifapentine were described to have enormously highly antibacterial activities[45] in the middle of these three antibacterial standard drugs; ampicillin was used as an antibacterial standard to match with the synthesized compounds (4a–t). The results of antifungal and antibacterial screening were summarized in Table . The results exposed that maximum of the compounds have shown adequate to superb inhibitory activity against the three tested bacteria. The electronic property of the compounds has an adjacent correlation with their biological activity.[46] Compounds 4e, 4f, and 4i showed decent antibacterial activity against all four bacterial pathogens because of the presence of withdrawing groups (−NO2 and −CF3) and electron-donating groups (−OH and −OCH3) in the molecule (Figure ). Compound 4f showed good antibacterial activity against the Gram-positive strains, P. aeruginosa, E. coli, Staphylococcus aureus, and S. pyogenes. We imagine that the presence of −OH and −OCH3 moieties in the molecule could contribute significantly to the antibacterial activities. Compound 4e and 4i showed decent antibacterial activity against P. aeruginosa and E. coli and less activity against S. aureus. Compounds 4e, 4f, 4i, and 4n showed decent antibacterial activity against all bacterial strains (Schemes and 5).
Table 4

Antimicrobial Screening of 4-Oxo-6-aryl-2-thioxo-1,2,3,4-Tetrahydropyrimidine-5-carbonitriles (4a–t)a

 minimum inhibitory concentration (MIC) in μg/mL
compoundE. c. MTCC (443)P. a. MTCC (1688)S. a. MTCC (96)S. p. MTCC (442)C. a. MTCC (227)A. n. MTCC (282)
4a500100250250100500
4b250500500100500100
4c100100100100500250
4d100200250250500100
4e502550050500250
4f5012.525250100250
4g500100500250250500
4h100100200250100100
4i12.52510050500250
4j10050010010010025
4k50050050025012.550
4l50025050025050100
4m1001002505050100
4n25100250100500250
4o50100100100500250
4p100200100250500200
4q200100250200100100
4r500200200250100250
4s250500100500250100
4t5050200200250100
ampicillin100100250100  
griseofulvin    500100

E. c., Escherichia coli; P. a., Pseudomonas aeruginosa; S. a.,Staphylococcus aureus; S. p., Streptococcus pyogenes; C.a., Candida albicans; A. n., Aspergillus niger.

Figure 4

Structure–activity relationship of hybrid compounds.

Synthesis of Ethyl 6-Methyl-2-oxo-4-aryl-1,2,3,4-tetrahydropyrimidine-5-carboxylates (4aa–nn) by Using DIPEAc as RTIL

Reaction conditions: aldehyde (1aa–nn) (3 mmol), ethylcyanoacetate/ethyl acetoacetate (3 mmol), thiourea/urea (3.2 mmol) in DIPEAc (4 mL), stirred at room temp; isolated yields, melting points are in good contact with those reported in the literature.[36,50,51] E. c., Escherichia coli; P. a., Pseudomonas aeruginosa; S. a.,Staphylococcus aureus; S. p., Streptococcus pyogenes; C.a., Candida albicans; A. n., Aspergillus niger. Compounds 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles (4a–t) were also screened for their in vitro antifungal activity against two fungal strains such as A. niger and Candida albicans by using the microdilution method.[47] The results of antifungal screening were summarized in Table . Antifungal screening results revealed that several compounds showed excellent inhibition against the tested fungal strains compared to standard drug griseofulvin. Compounds 4j, 4k, and 4m showed potent activities against all of the tested fungal strains. It may be because of the presence of the active pyrimidine ring and electron-donating and electron-withdrawing groups on the phenyl ring and presence of thiophene.

Conclusions

In conclusion, an environmentally and highly efficient green methodology has been established for the synthesis of functionalized 1,2,3,4-tetrahydropyrimidine derivatives using an inexpensive and recoverable room-temperature DIPEAc catalytic solvent-free system. This, to the best of our knowledge, has no examples. This reaction scheme exposes a number of advantages, such as uniqueness, high atom efficiency, mild reaction conditions, clean reaction profiles, easy workup procedure, and ecofriendliness. Furthermore, the prevention of hazardous organic solvents during the entire procedure (synthesis, ionic liquid preparation, and workup procedure) makes it a convenient and attractive method for the synthesis of these important compounds. In addition, a series of 4-oxo-6-aryl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitriles analogs were screened for their in vitro antifungal and antibacterial activities. The consequences exposed that compounds 4e, 4f, and 4i presented better antibacterial potency which is equal to the reference drug ampicillin. Compounds 4j, 4k, and 4m were originated to be decent antifungal activity matched to the standard drug griseofulvin.

Experimental Section

Materials and Methods

All of the reagents used were of laboratory grade. Melting points of all of the synthesized analogues were resolute in an open capillary tube and are uncorrected. The progress of the reaction was monitored by thin-layer chromatography on Merck’s silica plates, and imagining was accomplished by iodine/ultraviolet light. IR spectra were acquired on a Bruker ALPHA (Eco-ATR) spectrometer. 1H NMR spectra were recorded with a Bruker AvIII HD-400 MHz spectrometer operating at 400 MHz using DMSO solvent and tetramethylsilane (TMS) as the internal standard and chemical shift in δ ppm. Mass spectra were recorded on a Waters UPLCTQD (ESI-MS and APCI-MS) instrument, and elemental analysis was recorded on the CHNS auto-analyzer (Thermo Fischer EA1112 SERIES). Chemical shifts (δ) are reported in parts per million using TMS as an internal standard. The splitting pattern abbreviations are designed as singlet (s); doublet (d); double doublet (dd); bs (broad singlet), triplet (t); quartet (q); and multiplets (m).

Preparation of DIPEAc

General Procedure for the Synthesis of Diisopropylethylammonium Acetate (DIPEAc)

A mixture of N,N-diisopropylethylamine (3 mmol) and acetic acid (3 mmol) was stirred at 0–10 °C for 20 min. The viscous liquid, diisopropylethylammonium acetate, was achieved.[48,49]

General Procedure for Synthesis of 4-Oxo-6-phenyl-2-thioxo-1,2,3,4-(tetrahydropyrimidine-5-carbonitrile)

A mixture of aldehyde (1a) (1 mmol), ethylcyanoacetate/ethyl acetoacetate (2) (1 mmol), and thiourea/urea (3) (1.2 mmol) in DIPEAc (4 mL) was stirred at room temperature; the evolution of reaction was supervised by thin-layer chromatography [ethyl acetate/N-hexane (3:7)] as a solvent after a stirring reaction mixture was cooled for 45 min and a poured on crushed ice. Thus, acquired solid was filtered, dried, and purified by crystallization using ethanol as a solvent. The result is summarized in Table . The synthesis compound is confirmed by mp, IR, NMR, and mass spectra.

Spectral Analysis of Compounds

4-Oxo-6-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4a)

IR (ATR, υ cm–1) characteristic absorptions: 2221.12 (CN stretching), 1722.36 (C=O stretching), 3244.37 (N–H stretching), 1448.54 (C=C aromatic stretching), 2902.28 (C–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.71 (s, 1H, NH), 8.96 (s, 1H, NH), 7.78–7.81 (d, 2H, Ar–H), 7.11–7.15 (d, 2H, Ar–H), 7.54–7.56 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 85.12, 118.62, 123.66, 128.62, 130.59, 131.52, 136.68, 138.64, 139.10, 162.22, 166.22, 183.29, 183.53 mass (LCMS): m/z [M + Na]+ calcd for C11H7N3OSNa+, 252.2; found, 252.2. Anal. Calcd for C11H7N3OS: N, 18.33; C, 57.63; S, 13.98; H, 3.08. Found: N, 18.33; C, 57.63; S, 13.98; H, 3.09.

4-(4-Chlorophenyl)-2-mercapto-6-oxo-1,6-dihydropyrimidine-5-carbonitrile (4b)

IR (ATR, υ cm–1) characteristic absorptions: 2205.85 (CN stretching), 1629.96 (C=O stretching), 3115.80 (N–H stretching), 1461.01 (C=C aromatic stretching), 2893.47 (C–H stretching) 896.64 (C–Cl stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.72 (s, 1H, NH), 8.97 (s, 1H, NH), 7.48–7.52 (d, 2H, Ar–H), 7.21–7.26 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 85.12, 119.53, 128.26, 130.22, 134.73, 135.19, 136.92, 162.66, 166.35, 184.23 mass (LCMS): m/z [M + Na]+ calcd for C11H6ClN3OSNa+, 286.7; found, 286.7. Anal. Calcd for C11H6ClN3OS: N, 15.94; C, 50.10; S, 12.16; H, 2.29. Found: N, 15.94; C, 50.10; S, 12.16; H, 2.29.

6-(4-Nitrophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4c)

IR (ATR, υ cm–1) characteristic absorptions: 2220.80 (CN stretching), 1630.96 (C=O stretching), 3145.80 (N–H stretching), 1460.01 (C=C aromatic stretching), 2800.47 C–H stretching) 890.64 (C–NO2 stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 8.1 (s, 1H, NH), 8.97 (s, 1H, NH), 7.48–7.52 (d, 2H, Ar–H), 7.21–7.26 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 74.7, 115.8, 123.3, 123.3, 134.73, 126.6, 126.6, 137.7, 147.1, 169.1; 166.9, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C11H6N4O3SNa+, 297.2; found, 297.2. Anal. Calcd for C11H6N4O3S: N, 20.43; C, 48.17; S, 11.69; H, 2.21. Found: N, 20.50; C, 48.23; S, 20.45; H, 2.28.

6-(4-Bromophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4d)

IR (ATR, υ cm–1) characteristic absorptions: 2200.80 (CN stretching), 1640.69 (C=O stretching), 3145.80 (N–H stretching), 1464.02 (C=C aromatic stretching), 2820.47 (C–H stretching) 900.64 (C–Br stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.66 (s, 1H, NH), 12.29 (s, 1H, NH), 7.68–7.70 (d, 2H, Ar–H), 7.33–7.38 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 75.4, 116.8, 122.3, 123.3, 128.6, 128.8, 126.6, 130.7, 131.6, 166.9; 169.7, 175.5 mass (LCMS): m/z [M + Na]+ calcd for C11H6BrN3OSNa+, 331.1; found, 331.2. Anal. Calcd for C11H6BrN3OS: N, 13.64; C, 42.88; S, 10.40; H, 1.96. Found: N, 13.60; C, 42.60; S, 10.20; H, 2.0.

6-(4-Methoxyphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4e)

IR (ATR, υ cm–1) characteristic absorptions: 2260.00 (CN stretching), 1620.69 (C=O stretching), 3245.80 (N–H stretching), 1520.02 (C=C aromatic stretching), 2850.26 (C–H stretching) 2830.12 (O–CH3 stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.66 (s, 1H, NH), 11.29 (s, 1H, NH), 7.52–7.54 (d, 2H, Ar–H), 6.94–6.98 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 55.08, 75.2, 115.8, 121.1, 123.7, 124.2, 129.8, 130.1, 159.8, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C12H9N3O2SNa+, 282.3; found, 282.3. Anal. Calcd for C12H9N3O2S: N, 16.21; C, 55.59; S, 12.36; H, 3.50. Found: N, 16.24; C, 55.60; S, 12.35; H, 3.50.

6-(3-Hydroxy-4-methoxyphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4f)

IR (ATR, υ cm–1) characteristic absorptions: 2200.80 (CN stretching), 1640.69 (C=O stretching), 3145.80 (N–H stretching), 1564.02 (C=C aromatic stretching), 2800.38 (C–H stretching) 2815.15 (O–CH3 stretching), 3305.10 (O–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.32 (s, 1H, NH), 11.99 (s, 1H, NH), 9.12 (s, 1H, OH), 7.12 (d, 1H, Ar–H), 6.69–6.76 (s, 2H, Ar–H), 3.80 (s, 3H, OCH3), 13C NMR (100 MHz, DMSO-d6, ppm): 56.3, 74.7, 112.1, 113.2, 115.9, 122.3, 127.9, 147.3, 149.4, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C12H9N3O3SNa+, 398.3; found, 398.3. Anal. Calcd for C12H9N3O3S: N, 15.26; C, 52.36; S, 11.65; H, 3.30. Found: N, 15.25; C, 52.35; S, 11.66; H, 3.52.

6-(4-Fluorophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4g)

IR (ATR, υ cm–1) characteristic absorptions: 2211.10 (CN stretching), 1640.69 (C=O stretching), 3250.80 (N–H stretching), 1540.02 (C=C aromatic stretching), 2790.26 (C–H stretching) 1250.11 (C–F stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.33 (s, 1H, NH), 12.39 (s, 1H, NH), 7.36–7.40 (d, 2H, Ar–H), 7.24–7.28 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 75.7, 115.4, 115.8, 128.2, 127.9, 127.2, 162.3, 167.1, 169.5, 166.9, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C11H6FN3OSNa+, 270.2; found, 270.2. Anal. Calcd for C11H6FN3OS: N, 15.55; C, 48.89; S, 12.97; H, 2.45. Found: N, 15.54; C, 48.85; S, 12.98; H, 2.44.

6-(2-Chlorophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4h)

IR (ATR, υ cm–1) characteristic absorptions: 2205.85 (CN stretching), 1629.96 (C=O stretching), 3115.80 (N–H stretching), 1461.01 (C=C aromatic stretching), 2893.47 (C–H stretching) 906.64 (C–Cl stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.66 (s, 1H, NH), 11.43 (s, 1H, NH), 7.48–7.52 (d, 2H, Ar–H), 7.21–7.26 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 85.12, 115.8, 126.7, 127.8, 129.3, 129.9, 131.1, 135.3, 166.9, 169.1; 175.2 mass (LCMS): m/z [M + Na]+ calcd for C11H6ClN3OSNa+, 286.7; found, 286.7. Anal. Calcd for C11H6ClN3OS: N, 15.02; C, 51.52; S, 11.46; H, 3.60. Found: N, 15.10; C, 51.45; S, 11.40; H, 3.65.

6-(2-Nitrophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4i)

IR (ATR, υ cm–1) characteristic absorptions: 2220.80 (CN stretching), 1630.96 (C=O stretching), 3145.80 (N–H stretching), 1460.01 (C=C aromatic stretching), 2800.47 (C–H stretching) 890.64 (C–NO2 stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.99 (s, 1H, NH), 12.39 (s, 1H, NH), 7.60–7.76 (d, 2H, Ar–H), 7.89–8.26 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 76.7, 116.8, 123.8, 127.3, 128.8, 130.0, 134.2, 145.6, 147.1, 166.2; 169.2, 178.2 mass (LCMS): m/z [M + Na]+ calcd for C11H6N4O3SNa+, 297.2; found, 297.2. Anal. Calcd for C11H6N4O3S: N, 20.43; C, 48.17; S, 11.69; H, 2.21. Found: N, 20.50; C, 48.23; S, 20.45; H, 2.28.

6-(2-Bromophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4j)

IR (ATR, υ cm–1) characteristic absorptions: 2250.80 (CN stretching), 1610.69 (C=O stretching), 3120.80 (N–H stretching), 1464.02 (C=C aromatic stretching), 2820.47 (C–H stretching) 960.64 (C–Br stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.53 (s, 1H, NH), 11.29 (s, 1H, NH), 7.49–7.53 (d, 2H, Ar–H), 7.33–7.38 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 76.3, 115.2, 118.6, 127.5, 128.6, 132.6, 138.2, 166.9, 169.1, 166.9; 169.7, 176.5 mass (LCMS): m/z [M + Na]+ calcd for C11H6BrN3OSNa+, 331.1; found, 331.2. Anal. Calcd for C11H6BrN3OS: N, 13.64; C, 42.88; S, 10.40; H, 1.96. Found: N, 13.10; C, 42.20; S, 10.30; H, 2.01.

4-Oxo-2-thioxo-6-(4-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4k)

IR (ATR, υ cm–1) characteristic absorptions: 2190.80 (CN stretching), 1710.69 (C=O stretching), 3220.80 (N–H stretching), 1464.02 (C=C aromatic stretching), 2820.47 (C–H stretching) 1000.64 (C–CF3 stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.26 (s, 1H, NH), 12.43 (s, 1H, NH), 7.42–7.46 (d, 2H, Ar–H), 7.27–7.30 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 76.8, 115.8, 124.1, 125.0, 125.1, 129.4, 130.2, 134.9, 166.8, 169.2; 178.3 mass (LCMS): m/z [M + Na]+ calcd for C12H6F3N3OSNa+, 320.2; found, 320.2. Anal. Calcd for C12H6F3N3OS: N, 14.14; C, 48.49; S, 10.79; H, 2.03. Found: N, 14.15; C, 48.48; S, 10.78; H, 2.08.

6-(3,4-Dimethoxy-5-methylphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4l)

IR (ATR, υ cm–1) characteristic absorptions: 2220.80 (CN stretching), 1650.69 (C=O stretching), 3045.80 (N–H stretching), 1564.02 (C=C aromatic stretching), 2800.38 (C–H stretching) 2875.15 (O–CH3 stretching), 2875.15 (O–CH3 stretching), 3305.10. 1H NMR (400 MHz, DMSO-d6, ppm): 12.66 (s, 1H, NH), 12.39 (s, 1H, NH), 7.14 (s, 1H, Ar–H), 6.84 (s, 1H, Ar–H), 3.83 (s, 3H, OCH3), 3.68 (s, 3H, OCH3), 13C NMR (100 MHz, DMSO-d6, ppm): 16.1, 56.1, 60.3, 108.5, 115.7, 119.9, 125.4, 127.4, 145.2, 151.2, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C14H13N3O3SNa+, 326.3; found, 326.3. Anal. Calcd for C14H13N3O3S: N, 13.85; C, 55.43; S, 10.57; H, 4.32. Found: N, 13.85; C, 55.43; S, 10.57; H, 4.32.

4-Oxo-6-(thiophen-2-yl)-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4m)

IR (ATR, υ cm–1) characteristic absorptions: 2200.60 (CN stretching), 170.59 (C=O stretching), 3145.90 (N–H stretching), 1570.02 (C=C aromatic stretching), 2814.38 (C–H stretching) (thiophene ring stretching), 3305.10. 1H NMR (400 MHz, DMSO-d6, ppm): 11.23 (s, 1H, NH), 11.00 (s, 1H, NH), 7.95 (s, 1H, Ar–H), 7.36 (t, 1H, Ar–H), 7.85 (s, 1H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 80.7, 115.8, 127.1, 128.3, 130.5, 136.6, 166.9, 176.8, 177.1 mass (LCMS): m/z [M + Na]+ calcd for C9H5N3OS2Na+, 258.3; found, 258.3. Anal. Calcd for C9H5N3OS2: N, 17.86; C, 45.95; S, 27.25; H, 2.14. Found: N, 17.85; C, 45.96; S, 27.24; H, 2.15.

6-(3-Hydroxyphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4n)

IR (ATR, υ cm–1) characteristic absorptions: 2200.80 (CN stretching), 1640.69 (C=O stretching), 3145.80 (N–H stretching), 1564.02 (C=C aromatic stretching), 2800.38 (C–H stretching) 3305.10 (O–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.32 (s, 1H, NH), 11.99 (s, 1H, NH), 9.45 (s, 1H, OH), 7.24–7.28 (d, 1H, Ar–H), 6.69–6.83 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 75.7, 112.1, 115.1, 115.8, 120.9, 130.0, 135.6, 158.4, 149.4, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C11H7N3O2SNa+, 268.2; found, 268.2. Anal. Calcd for C11H7N3O2S: N, 17.13; C, 53.87; S, 13.07; H, 2.88. Found: N, 17.14; C, 53.88; S, 13.06; H, 2.87.

6-(4-Hydroxyphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4o)

IR (ATR, υ cm–1) characteristic absorptions: 2212.80 (CN stretching), 1660.69 (C=O stretching), 3100.80 (N–H stretching), 1564.02 (C=C aromatic stretching), 2800.38 (C–H stretching) 3300.10 (O–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.32 (s, 1H, NH), 11.99 (s, 1H, NH), 9.45 (s, 1H, OH), 7.31–7.35 (d, 1H, Ar–H), 6.35–6.39 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 75.7, 112.1, 115.1, 115.8, 120.9, 130.0, 135.6, 158.4, 149.4, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C11H7N3O2SNa+, 268.2; found, 268.2. Anal. Calcd for C11H7N3O2S: N, 17.13; C, 53.87; S, 13.07; H, 2.88. Found: N, 17.14; C, 53.88; S, 13.06; H, 2.89.

6-(3-Cyanophenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4p)

IR (ATR, υ cm–1) characteristic absorptions: 2212.80 (CN stretching), 2160.80, (CN stretching), 1660.69 (C=O stretching), 3100.80 (N–H stretching), 1600.02 (C=C aromatic stretching), 2800.38 (C–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.66 (s, 1H, NH), 12.39 (s, 1H, NH), 9.45 (s, 1H, OH), 7.80–7.83 (d, 1H, Ar–H), 7.61 (t, 1H, Ar–H), 7.89 (s, 1H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 75.2, 112.5, 115.8, 118.8, 129.3, 129.6, 131.4, 132.6, 134.9, 166.9, 169.1, 175.4 mass (LCMS): m/z [M + Na]+ calcd for C12H6N4OSNa+, 277.3; found, 277.3. Anal. Calcd for C12H6N4OS: N, 22.04; C, 56.59; S, 12.61; H, 2.38. Found: N, 22.05; C, 56.58; S, 12.62; H, 2.37.

6-(2-Hydroxyphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4q)

IR (ATR, υ cm–1) characteristic absorptions: 2220.10 (CN stretching), 1645.69 (C=O stretching), 3105.60 (N–H stretching), 1530.02 (C=C aromatic stretching), 2812.38 (C–H stretching) 3301.00 (O–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.32 (s, 1H, NH), 11.99 (s, 1H, NH), 9.45 (s, 1H, OH), 7.31–7.35 (d, 1H, Ar–H), 6.35–6.39 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 75.7, 112.1, 115.1, 115.8, 120.9, 130.0, 135.6, 158.4, 149.4, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C11H7N3O2SNa+, 268.2; found, 268.2. Anal. Calcd for C11H7N3O2S: N, 17.13; C, 53.87; S, 13.07; H, 2.88. Found: N, 17.14; C, 53.88; S, 13.06; H, 2.89.

6-(4-Hydroxy-3-methoxyphenyl)-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4r)

IR (ATR, υ cm–1) characteristic absorptions: 2214.80 (CN stretching), 1630.69 (C=O stretching), 3142.80 (N–H stretching), 1564.02 (C=C aromatic stretching), 2800.38 (C–H stretching) 2820.25 (O–CH3 stretching), 3310.10 (O–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.32 (s, 1H, NH), 11.99 (s, 1H, NH), 9.12 (s, 1H, OH), 7.12 (d, 1H, Ar–H), 6.69–6.76 (s, 2H, Ar–H), 3.80 (s, 3H, OCH3), 13C NMR (100 MHz, DMSO-d6, ppm): 56.3, 74.7, 112.1, 113.2, 115.9, 122.3, 127.9, 147.3, 149.4, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C12H9N3O3SNa+, 398.3; found, 398.3. Anal. Calcd for C12H9N3O3S: N, 15.26; C, 52.36; S, 11.65; H, 3.30. Found: N, 15.27; C, 52.35; S, 11.66; H, 3.51.

4-Oxo-2-thioxo-6-(p-tolyl)-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4s)

IR (ATR, υ cm–1) characteristic absorptions: 2200.80 (CN stretching), 1640.69 (C=O stretching), 3145.80 (N–H stretching), 1464.02 (C=C aromatic stretching), 2820.47 (C–H stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.12 (s, 1H, NH), 12.31 (s, 1H, NH), 7.68–7.70 (d, 2H, Ar–H), 7.33–7.38 (d, 2H, Ar–H), 2.41 (s, 3H, CH3), 13C NMR (100 MHz, DMSO-d6, ppm): 21.3, 75.4, 116.8, 122.3, 123.3, 128.6, 128.8, 126.6, 130.7, 131.6, 166.9; 169.7, 175.5 mass (LCMS): m/z [M + Na]+ calcd for C12H9N3OSNa+, 266.3; found, 266.3. Anal. Calcd for C12H9N3OS: N, 17.27; C, 59.24; S, 13.18; H, 3.73. Found: N, 17.28; C, 59.25; S, 13.17; H, 3.74.

4-Oxo-6-(pyridin-3-yl)-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4t)

IR (ATR, υ cm–1) characteristic absorptions: 2221.10 (CN stretching), 1620.69 (C=O stretching), 3256.80 (N–H stretching), 1486.02 (C=C aromatic stretching), 3450.47 (pyridine ring stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.66 (s, 1H, NH), 12.39 (s, 1H, NH), 7.68–7.70 (d, 2H, Ar–H), 8.37 (s, 1H, Ar–H), 8.70 (s, 1H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 80.7, 115.8, 123.8, 131.6, 133.7, 149.5, 150.00, 166.9, 169.1, 175.2 mass (LCMS): m/z [M + Na]+ calcd for C10H6N4OSNa+, 253.2; found, 253.2. Anal. Calcd for C10H6N4OS: N, 24.33; C, 52.17; S, 13.92; H, 2.63. Found: N, 24.34; C, 52.18; S, 13.93; H, 2.64.

2,4-Dioxo-6-phenyl-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4u)

IR (ATR, υ cm–1) characteristic absorptions: 2218.10 (CN stretching), 1732.69 (C=O stretching), 3256.80 (N–H stretching), 1486.02 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.35 (s, 1H, NH), 10.98 (s, 1H, NH), 7.71–7.73 (d, 2H, Ar–H), 7.52–7.54 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 72.2, 115.8, 127.9, 128.3, 128.4, 128.6, 128.7, 131.6, 150.7, 161.6, 168.9 mass (LCMS): m/z [M + Na]+ calcd for C11H7N3O2Na+, 236.2; found, 236.2. Anal. Calcd for C11H7N3O2: N, 19.71; C, 61.97; H, 3.31. Found: N, 19.72; C, 61.98; H, 3.32.

6-(4-Chlorophenyl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4v)

IR (ATR, υ cm–1) characteristic absorptions: 2212.36 (CN stretching), 1640.69 (C=O stretching), 3301.80 (N–H stretching), 1510.02 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 11.10 (s, 1H, NH), 10.30 (s, 1H, NH), 7.44–7.48 (d, 2H, Ar–H), 7.28–7.32 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 73.4, 115.8, 120.2, 120.6, 128.8, 128.9, 129.7, 133.5, 150.7, 161.6, 168.9 mass (LCMS): m/z [M + Na]+ calcd for C11H6ClN3O2Na+, 270.6; found, 270.6. Anal. Calcd for C11H6ClN3O2: N, 16.97; C, 53.35; H, 2.44. Found: N, 16.96; C, 53.54; H, 2.45.

6-Butyl-4-oxo-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4w)

IR (ATR, υ cm–1) characteristic absorptions: 2200.26 (CN stretching), 1650.69 (C=O stretching), 3320.10 (N–H stretching), 1512.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 12.66 (s, 1H, NH), 8.14 (s, 1H, NH), 1.94 (t, 2H), 1.38 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 20.9, 22.8, 28.2, 64.8, 115.8, 116.2, 175.2, 182.4 mass (LCMS): m/z [M + Na]+ calcd for C9H11N3OSNa+, 232.3; found, 232.3. Anal. Calcd for C9H11N3OS: N, 20.08; C, 51.66; H, 5.30; S, 15.32. Found: N, 20.02; C, 51.67; H, 5.31; S, 15.31.

6-Butyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4x)

IR (ATR, υ cm–1) characteristic absorptions: 2203.22 (CN stretching), 1660.60 (C=O stretching), 1760.10 (C=O stretching), 3300.10 (N–H stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 10.80 (s, 1H, NH), 10.10 (s, 1H, NH), 1.84 (t, 2H), 1.48 (d, 2H, Ar–H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.6, 21.2, 22.7, 28.9, 85.4, 116.5, 150.2, 161.3, 173.5 mass (LCMS): m/z [M + Na]+ calcd for C9H11N3O2Na+, 216.2; found, 216.2. Anal. Calcd for C9H11N3O2: N, 21.75; C, 55.95; H, 5.74. Found: N, 21.71; C, 55.96; H, 5.73.

6-Butyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4y)

IR (ATR, υ cm–1) characteristic absorptions: 2203.22 (CN stretching), 1660.60 (C=O stretching), 3300.10 (N–H stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 10.50 (s, 1H, NH), 10.10 (s, 1H, NH), 1.98 (t, 2H), 1.30 (q, 1H), 1.38 (t, 2H), 0.93 (s, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.2, 21.1, 29.7, 64.9, 166.2, 175.2, 179.8 mass (LCMS): m/z [M + Na]+ calcd for C8H9N3OSNa+, 218.2; found, 218.2. Anal. Calcd for C8H9N3OS: N, 21.52; C, 49.22; H, 4.65; S, 16.42. Found: N, 21.51; C, 49.23; H, 4.64; S, 16.41.

2,4-Dioxo-6-propyl-1,2,3,4-tetrahydropyrimidine-5-carbonitrile (4z)

IR (ATR, υ cm–1) characteristic absorptions: 2203.22 (CN stretching), 1660.60 (C=O stretching), 1760.10 (C=O stretching), 3300.10 (N–H stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.50 (s, 1H, NH), 9.10 (s, 1H, NH), 1.88 (t, 2H), 1.40 (q, 1H), 1.38 (t, 2H), 0.98 (s, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 16.2, 23.1, 28.7, 65.9, 167.2, 176.2, 180.8 mass (LCMS): m/z [M + Na]+ calcd for C8H9N3OSNa+, 202.2; found, 202.2. Anal. Calcd for C8H9N3OS: N, 23.45; C, 53.63; H, 5.06. Found: N, 23.46; C, 53.63; H, 5.07.

Ethyl 6-Methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4aa)

IR (ATR, υ cm–1) characteristic absorptions: 3230.22 (NH stretching), 1697.60 (C=O stretching), 1760.10 (C=O stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.18 (s, 1H, NH), 7.73 (s, 1H, NH), 7.33–7.22 (m, 5H, Ar–H), 5.14 (d, 1H), 4.00–3.95 (q, 2H), 2.24 (s, 3H), 1.10–1.07 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.09, 17.79, 53.98, 59.21, 99.29, 126.26, 127.28, 128.41, 144.88, 148.37, 152.15, 165.36 mass (LCMS): m/z [M + Na]+ calcd for C14H16N2O3Na+, 283.3; found, 283.3. Anal. Calcd for C14H16N2O3: N, 10.76; C, 64.60; H, 6.20. Found: N, 10.77; C, 64.61; H, 6.21.

Ethyl 4-(2-Chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4bb)

IR (ATR, υ cm–1) characteristic absorptions: 3228.22 (NH stretching), 1677.00 (C=O stretching), 1645.10 (C=O stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.21 (s, 1H, NH), 7.74 (s, 1H, NH), 7.45–7.44 (d, 1H, Ar–H), 7.25–7.23 (t, 2H, Ar–H), 7.31–7.30 (d, 1H, Ar–H), 7.20–7.21 (t, 1H, Ar–H), 5.61 (d, 1H), 3.91–3.86 (q, 2H), 2.30 (s, 2H), 1.00–0.97 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 13.95, 17.77, 53.40, 59.21, 90.83, 128.36, 131.75, 143.78, 148.68, 151.79, 165.36 mass (LCMS): m/z [M + Na]+ calcd for C14H15ClN2O3Na+, 317.7; found, 317.7. Anal. Calcd for C14H15ClN2O3: N, 9.50; C, 57.05; H, 5.13. Found: N, 9.51; C, 57.04; H, 5.13.

Ethyl 4-(4-Chlorophenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4cc)

IR (ATR, υ cm–1) characteristic absorptions: 3228.22 (NH stretching), 1677.00 (C=O stretching), 1645.10 (C=O stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.21 (s, 1H, NH), 7.74 (s, 1H, NH), 7.40–7.38 (d, 2H, Ar–H), 7.25–7.23 (d, 2H, Ar–H), 5.14 (d, 1H), 4.01–3.95 (q, 2H), 2.24 (s, 3H), 1.11–1.07 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.5, 17.77, 53.40, 59.21, 90.83, 128.36, 131.75, 143.78, 148.68, 151.79, 165.36 mass (LCMS): m/z [M + Na]+ calcd for C14H15ClN2O3Na+, 317.7; found, 317.7. Anal. Calcd for C14H15ClN2O3: N, 9.50; C, 57.05; H, 5.13. Found: N, 9.51; C, 57.04; H, 5.13.

Ethyl 6-Methyl-4-(3-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4dd)

IR (ATR, υ cm–1) characteristic absorptions: 3323.12 (NH stretching), 1677.00 (C=O stretching), 1685.10 (C=O stretching), 1562.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.33 (s, 1H, NH), 8.08 (s, 1H, NH), 8.16 (s, 1H, NH) 8.14–8.12 (d, 1H, Ar–H), 7.70–7.69 (d, 1H, Ar–H), 7.67–7.63 (t, 1H, Ar–H), 5.30 (s, 1H), 4.01–3.94 (q, 2H), 2.27 (s, 3H), 1.11–1.08 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 13.97, 17.81, 53.53, 59.34, 98.32, 120.96, 122.30, 130.19, 132.94, 146.96, 147.63, 149.63, 151.63, 166.03 mass (LCMS): m/z [M + Na]+ calcd for C14H15N3O5Na+, 328.3; found, 328.3. Anal. Calcd for C14H15N3O5: N, 13.76; C, 55.08; H, 4.95. Found: N, 13.77; C, 55.09; H, 4.96.

Ethyl 6-Methyl-4-(4-nitrophenyl)-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4ee)

IR (ATR, υ cm–1) characteristic absorptions: 3224.12 (NH stretching), 1697.00 (C=O stretching), 1641.10 (C=O stretching), 1562.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.35 (s, 1H, NH), 8.22–8.20 (d, 2H), 7.88 (s, 1H) 7.51–7.49 (d, 2H, Ar–H), 5.27 (d, 1H, Ar–H), 4.01–3.95 (q, 2H, Ar–H), 2.26 (s, 3H), 1.11–1.07 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.02, 17.81, 53.67, 59.34, 98.32, 123.80, 127.64, 146.71, 149.36, 151.72, 151.98, 165.04 mass (LCMS): m/z [M + Na]+ calcd for C14H15N3O5Na+, 328.3; found, 328.3. Anal. Calcd for C14H15N3O5: N, 13.76; C, 55.08; H, 4.95. Found: N, 13.77; C, 55.09; H, 4.96.

Ethyl 4-(4-Methoxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4ff)

IR (ATR, υ cm–1) characteristic absorptions: 3230.12 (NH stretching), 1701.00 (C=O stretching), 1645.10 (C=O stretching), 1562.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.15 (s, 1H, NH), 7.66 (s, 1H) 7.15–7.13 (d, 2H, Ar–H), 6.88–6.85 (d, 2H, Ar–H), 5.09 (d, 1H), 4.00–3.94 (q, 2H), 3.71 (s, 3H), 2.23 (s, 3H), 1.11–1.08 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.10, 17.75, 53.33, 55.05, 59.15, 99.58, 113.17, 127.39, 137.05, 148.01, 152.16, 158.44, 165.38 mass (LCMS): m/z [M + Na]+ calcd for C15H18N2O4Na+, 313.3; found, 313.3. Anal. Calcd for C15H18N2O4: N, 9.65; C, 62.06; H, 6.25. Found: N, 9.66; C, 62.06; H, 6.25.

Ethyl 6-Methyl-2-oxo-4-(thiophen-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4gg)

IR (ATR, υ cm–1) characteristic absorptions: 3230.12 (NH stretching), 1701.00 (C=O stretching), 1646.10 (C=O stretching), 1562.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.31 (s, 1H, NH), 7.90 (s, 1H) 7.35–7.34 (d, 1H, Ar–H), 6.93–6.88 (dd, 2H, Ar–H), 5.41 (d, 1H), 4.08–4.03 (q, 2H), 2.21 (s, 3H), 1.18–1.14 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.15, 17.68, 49.35, 59.35, 99.78, 123.50, 124.63, 126.66, 148.65, 148.79, 152.23, 165.03 mass (LCMS): m/z [M + Na]+ calcd for C12H14N2O3SNa+, 289.3; found, 289.3. Anal. Calcd for C12H14N2O3S: N, 10.52; C, 54.12; H, 5.30. Found: N, 10.52; C, 54.12; H, 5.30.

Ethyl 6-Methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4hh)

IR (ATR, υ cm–1) characteristic absorptions: 3230.12 (NH stretching), 3107.02 (NH stretching), 1697.00 (C=O stretching), 1697.43.10 (C=O stretching), 1562.12 (C=C aromatic stretching), 1H NMR (400 MHz, DMSO-d6, ppm): 9.18 (s, 1H, NH), 7.73 (s, 1H) 7.33–7.22 (d, 1H, Ar–H), 5.14 (d, 1H), 4.08–3.95 (q, 2H), 2.24 (s, 3H), 1.10–1.07 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.09, 17.79, 53.98, 59.21, 99.29, 126.26, 127.28, 128.41, 144.88, 148.37, 152.15, 165.36 mass (LCMS): m/z [M + Na]+ calcd for C14H16N2O2SNa+, 299.3; found, 299.3. Anal. Calcd for C14H16N2O2S: N, 10.14; C, 60.85; H, 5.84; S, 11.60. Found: N, 1; C, 54.12; H, 5.84, S, 11.60.

Ethyl 4-(4-Chlorophenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4ii)

IR (ATR, υ cm–1) characteristic absorptions: 3228.22 (NH stretching), 1677.00 (C=O stretching), 1645.10 (C=O stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.21 (s, 1H, NH), 7.74 (s, 1H, NH), 7.40–7.38 (d, 2H, Ar–H), 7.25–7.23 (d, 2H, Ar–H), 5.14 (d, 1H), 4.01–3.95 (q, 2H), 2.24 (s, 3H), 1.11–1.07 (t, 3H) 13C NMR (100 MHz, DMSO-d6, ppm): 14.5, 17.77, 53.40, 59.21, 90.83, 128.36, 131.75, 143.78, 148.68, 151.79, 165.36 mass (LCMS): m/z [M + Na]+ calcd for C14H15ClN2O2SNa+, 333.8; found, 333.8. Anal. Calcd for C14H15ClN2O2S: N, 9.01; C, 54.10; H, 4.86; S, 10.32. Found: N, 9.51; C, 57.04; H, 5.13; S, 10.32.

Ethyl 4-(4-Methoxyphenyl)-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4jj)

IR (ATR, υ cm–1) characteristic absorptions: 3232.12 (NH stretching), 1721.00 (C=O stretching), 1646.10 (C=O stretching), 1562.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.16 (s, 1H, NH), 7.64 (s, 1H) 7.14–7.13 (d, 2H, Ar–H), 6.88–6.85 (d, 2H, Ar–H), 5.09 (d, 1H), 4.00–3.94 (q, 2H), 3.71 (s, 3H), 2.23 (s, 3H), 1.11–1.08 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.10, 17.75, 53.33, 55.05, 59.15, 99.58, 113.17, 127.39, 137.05, 148.01, 152.16, 158.44, 165.38 mass (LCMS): m/z [M + Na]+ calcd for C15H18N2O3SNa+, 329.4; found, 329.4. Anal. Calcd for C15H18N2O3S: N, 9.14; C, 58.80; H, 5.92; S, 10.46. Found: N, 9.15; C, 58.80; H, 5.15; S, 10.46.

Ethyl 6-Methyl-4-propyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4kk)

IR (ATR, υ cm–1) characteristic absorptions: 3232.12 (NH stretching), 1721.00 (C=O stretching), 1562.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.65 (s, 1H, NH), 8.10 (s, 1H) 4.51–3.72 (m, 3H), 2.16 (s, 3H), 1.46–1.23 (m, 4H), 1.19 (t, 3H), 0.85 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.23, 14.69, 17.47, 18.17, 50.25, 59.52, 99.86, 136.28, 162.66, 174.35 mass (LCMS): m/z [M + Na]+ calcd for C11H18N2O2SNa+, 265.3; found, 265.3. Anal. Calcd for C11H18N2O2S: N, 11.56; C, 54.52; H, 7.49; S, 13.23. Found: N, 11.56; C, 54.52; H, 7.49; S, 13.23.

Ethyl 4-Hexyl-6-methyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4ll)

IR (ATR, υ cm–1) characteristic absorptions: 3332.12 (NH stretching), 1691.00 (C=O stretching), 1552.12 (C=C aromatic stretching). 1H NMR (400 MHz, DMSO-d6, ppm): 9.75 (s, 1H, NH), 8.23 (s, 1H) 4.11–3.88 (m, 3H), 2.16 (s, 3H), 1.46–1.23 (m, 4H),1.18 (t, 3H),0.85 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.01, 14.26, 17.82, 21.95, 36.52, 49.99, 59.07, 99.39, 136.40, 160.83, 177.38 mass (LCMS): m/z [M + Na]+ calcd for C14H24N2O2SNa+, 307.4; found, 307.4. Anal. Calcd for C14H24N2O2S: N, 9.85; C, 59.12; H, 8.51; S, 11.27. Found: N, 9.85; C, 59.12; H, 8.51; S, 11.27.

Ethyl 6-Methyl-2-oxo-4-propyl-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4mm)

IR (ATR, υ cm–1) characteristic absorptions: 3240.10 (N–H stretching), 1628.75 (C=O stretching), 3140.15, 1393.29 (C=C aromatic stretching), 2955.56 (C–H stretching) 1508.94 (CH3 bending). 1H NMR (400 MHz, DMSO-d6, ppm): 8.95 (s, 1H, NH), 7.35 (s, 1H) 4.52–3.71 (m, 3H), 2.16 (s, 3H), 1.44–1.25 (m, 4H), 1.19 (t, 3H), 0.85 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.23, 14.69, 17.47, 18.17, 50.25, 59.52, 99.86, 148.77, 153.27, 165.83 mass (LCMS): m/z [M + Na]+ calcd for C11H18N2O3Na+, 249.3; found, 249.3. Anal. Calcd for C11H18N2O3: N, 12.38; C, 58.39; H, 8.02. Found: N, 12.38; C, 58.39; H, 8.01.

Ethyl 4-Butyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate (4nn)

IR (ATR, υ cm–1) characteristic absorptions: 3230.21 (N–H stretching), 1640.75 (C=O stretching), 3146.15, 1343.29 (C=C aromatic stretching), 2945.56 (C–H stretching) 1518.94 (CH3 bending). 1H NMR (400 MHz, DMSO-d6, ppm): 8.95 (s, 1H, NH), 7.35 (s, 1H) 4.52–3.71 (m, 3H), 2.16 (s, 3H), 1.44–1.25 (m, 4H), 1.19 (t, 3H), 0.85 (t, 3H), 13C NMR (100 MHz, DMSO-d6, ppm): 14.23, 14.69, 17.47, 18.17, 50.25, 59.52, 99.86, 148.77, 153.27, 165.83 mass (LCMS): m/z [M + Na]+ calcd for C12H20N2O3Na+, 263.03; found, 263.03. Anal. Calcd for C12H20N2O3: N, 11.66; C, 59.98; H, 8.39. Found: N, 11.66; C, 59.98; H, 8.39.
  19 in total

Review 1.  Chemistry and biology of multicomponent reactions.

Authors:  Alexander Dömling; Wei Wang; Kan Wang
Journal:  Chem Rev       Date:  2012-03-22       Impact factor: 60.622

2.  Prediction of the Fate of Organic Compounds in the Environment From Their Molecular Properties: A Review.

Authors:  Laure Mamy; Dominique Patureau; Enrique Barriuso; Carole Bedos; Fabienne Bessac; Xavier Louchart; Fabrice Martin-Laurent; Cecile Miege; Pierre Benoit
Journal:  Crit Rev Environ Sci Technol       Date:  2015-06-18       Impact factor: 12.561

3.  Novel cycloalkylthiophene-imine derivatives bearing benzothiazole scaffold: synthesis, characterization and antiviral activity evaluation.

Authors:  Shaoyong Ke; Yanhong Wei; Ziwen Yang; Kaimei Wang; Ying Liang; Liqiao Shi
Journal:  Bioorg Med Chem Lett       Date:  2013-07-22       Impact factor: 2.823

4.  Green and Sustainable Solvents in Chemical Processes.

Authors:  Coby J Clarke; Wei-Chien Tu; Oliver Levers; Andreas Bröhl; Jason P Hallett
Journal:  Chem Rev       Date:  2018-01-04       Impact factor: 60.622

5.  Synthesis, SAR and molecular docking studies of benzo[d]thiazole-hydrazones as potential antibacterial and antifungal agents.

Authors:  Gao-Feng Zha; Jing Leng; N Darshini; T Shubhavathi; H K Vivek; Abdullah M Asiri; Hadi M Marwani; K P Rakesh; N Mallesha; Hua-Li Qin
Journal:  Bioorg Med Chem Lett       Date:  2017-05-13       Impact factor: 2.823

6.  One-pot three-component domino protocol for the synthesis of novel pyrano[2,3-d]pyrimidines as antimicrobial and anti-biofilm agents.

Authors:  Lingala Suresh; Y Poornachandra; S Kanakaraju; C Ganesh Kumar; G V P Chandramouli
Journal:  Org Biomol Chem       Date:  2015-06-09       Impact factor: 3.876

7.  Ionic liquid as catalyst and reaction medium. The dramatic influence of a task-specific ionic liquid, [bmIm]OH, in Michael addition of active methylene compounds to conjugated ketones, carboxylic esters, and nitriles.

Authors:  Brindaban C Ranu; Subhash Banerjee
Journal:  Org Lett       Date:  2005-07-07       Impact factor: 6.005

Review 8.  Synergy between essential oil components and antibiotics: a review.

Authors:  Wendy T Langeveld; Edwin J A Veldhuizen; Sara A Burt
Journal:  Crit Rev Microbiol       Date:  2013-02-28       Impact factor: 7.624

9.  An enantioselective biginelli reaction catalyzed by a simple chiral secondary amine and achiral brønsted acid by a dual-activation route.

Authors:  Junguo Xin; Lu Chang; Zongrui Hou; Deju Shang; Xiaohua Liu; Xiaoming Feng
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

10.  Hydrogen-Bonding Interactions in Pyridinium-Based Ionic Liquids and Dimethyl Sulfoxide Binary Systems: A Combined Experimental and Computational Study.

Authors:  Yaqin Zhang; Hongyan He; Suojiang Zhang; Maohong Fan
Journal:  ACS Omega       Date:  2018-02-12
View more
  5 in total

1.  Cesium salt of 2-molybdo-10-tungstophosphoric acid as an efficient and reusable catalyst for the synthesis of uracil derivatives via a green route.

Authors:  Kiran R Khillare; Dipak S Aher; Laxmikant D Chavan; Sunil G Shankarwar
Journal:  RSC Adv       Date:  2021-10-20       Impact factor: 4.036

2.  Triethylammonium Hydrogen Sulfate [Et3NH][HSO4]-Catalyzed Rapid and Efficient Multicomponent Synthesis of Pyrido[2,3-d]pyrimidine and Pyrazolo[3,4-b]pyridine Hybrids.

Authors:  Chetan Jadhav; Amol Nipate; Asha Chate; Charansingh Gill
Journal:  ACS Omega       Date:  2021-07-02

3.  Synthesis of a Zirconium Complex of an N,O-type p-tert-Butylcalix[4]arene and Its Application in Some Multicomponent Reactions.

Authors:  Varun Rawat; Arkadi Vigalok; Anshu Kumar Sinha; Garima Sachdeva; Chandra Mohan Srivastava; Gyandshwar K Rao; Arun Kumar; Mandeep Singh; Komal Rathi; Ved Prakash Verma; Bhupender Yadav; Amit Kumar Pandey; Monika Vats
Journal:  ACS Omega       Date:  2022-08-04

Review 4.  Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions.

Authors:  Francisco Sánchez-Sancho; Marcos Escolano; Daniel Gaviña; Aurelio G Csáky; María Sánchez-Roselló; Santiago Díaz-Oltra; Carlos Del Pozo
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30

5.  Sulfamic acid pyromellitic diamide-functionalized MCM-41 as a multifunctional hybrid catalyst for melting-assisted solvent-free synthesis of bioactive 3,4-dihydropyrimidin-2-(1H)-ones.

Authors:  Ehsan Valiey; Mohammad G Dekamin; Zahra Alirezvani
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.